129 results
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
of shares with preferential rights that may be authorized in the future.
Access to Corporate Records
Under the Israeli Companies Law, all shareholders … Securities Authority. Any of our shareholders may request access to review any document in our possession that relates to any action or transaction
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
30 Jan 24
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
7:24am
of the distribution agreement are applicable to such indication.
Ewopharma is a pharmaceutical sales and marketing firm that helps pharma companies access
F-3/A
CANF
Can-Fite Biopharma Ltd
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
in the future.
Access to Corporate Records
Under the Israeli Companies Law, all shareholders of a company generally have the right to review minutes … access to review any document in our possession that relates to any action or transaction with a related party, interested party or office holder
F-3
6ar9n ie2366ph1gti7
12 Dec 23
Shelf registration (foreign)
4:15pm
POS AM
hla56nq
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
fivhv7lp1m7 gog
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.2
tz2s6d3or2d14771bj
31 Aug 23
Report of Foreign Private Issuer
7:12am
6-K
EX-99.1
9gmxvfruxdrxy6
24 Aug 23
Report of Foreign Private Issuer
7:19am
POS AM
vdz6zx07a
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
5isbq7z38nuwjzitp
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
POS AM
g4inpivsrcezx65ae
26 Aug 22
Prospectus update (post-effective amendment)
4:31pm
6-K
EX-99.2
ku02y0mk s1lq0
25 Aug 22
Report of Foreign Private Issuer
7:16am
6-K
EX-99.1
wv8dyothj 12o
9 Jun 22
Can-Fite Announces Publication of Clinical Study Data for Piclidenoson and Namodenoson in Scientific Journal
7:03am
POS AM
7u9enygez72tr7qepq7w
25 Mar 22
Prospectus update (post-effective amendment)
4:30pm
424B3
i841n3 jlbcp4
14 Jan 22
Prospectus supplement
4:30pm
F-3
ccen8
7 Jan 22
Shelf registration (foreign)
4:31pm